C-3 and C-17 modified triterpenoids as HIV-1 inhibitors
Abstract:
Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, betulinic acid derivatives that possess unique antiviral activity are provided as HIV maturation inhibitors, as represented by compounds of Formula I: These compounds are useful for the treatment of HIV and AIDS.
Public/Granted literature
Information query
Patent Agency Ranking
0/0